16th Oct 2020 06:04
Frontier IP Group PLC - intellectual property commercialisation firm - Says portfolio company Vaccine Group enters into collaboration with Pirbright Institute and ECO Animal Health Group PLC to tackle one of the most economically damaging diseases to the global pig industry. The collaboration will see Vaccine Group use its novel vaccine technology to develop a vaccine to combat porcine respiratory and reproductive syndrome virus. Together, type-1 and type-2 reproductive syndrome virus are estimated to cost European pig farmers EUR1.5 billion a year and those in the US, USD600 million.
Current stock price: 65.33 pence
Year-to-date change: down 1.8%
By Evelina Grecenko; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Frontier Ip